SUDARSHAN PHARMA INDUSTRIES LIMITED

BSE: SUDARSHAN543828ISIN INE00TV01023

Commodities
Specialty Chemicals

Share price

₹32.45-0.03 (-0.09%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

Splits and bonuses

22 Nov 2024 · Split 10:1 (₹10 → ₹1)

52W high: ₹42.79
52W low: ₹18.50
Off 52W high: -24.16%
1M return: -12.53%
3M return: -0.12%
6M return: +7.24%
1Y return: +13.26%
20D avg volume: 1,40,405
50 DMA: ₹37.69
200 DMA: ₹32.71

Key ratios Consolidated

Market cap: ₹810.14 Cr
Current price: ₹32.45
52W high / low: ₹42.79 / ₹18.50
Face value: ₹1.00
P/E: 28.54
P/B: 4.22
EPS (TTM): ₹1.14
Book value / share: ₹7.68
ROE: —
ROCE: 30.30%
Operating margin: —
Net margin: —
Debt / equity: 1.81
Net debt: ₹282.35 Cr
Interest cover: 2.19
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 137.2 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	216.97	174.42	220.92	168.01	168.87	145.26	—	—
	1.93	1.22	4.12	1.52	1.86	1.21	—	—
	218.90	175.64	225.05	169.52	170.73	146.47	—	—
	208.10	168.13	209.34	164.33	166.50	141.06	—	—
	7.26	7.98	20.12	13.21	0.31	5.42	—	—
	192.13	168.73	192.61	148.81	171.18	139.53	—	—
	2.04	2.07	2.10	1.97	1.78	1.58	—	—
	10.36	8.21	7.53	6.28	5.94	5.96	—	—
	1.36	1.41	1.09	0.91	0.90	0.88	—	—
	10.51	6.70	8.57	7.36	5.57	3.42	—	—
	10.80	7.51	15.70	5.20	4.23	5.41	—	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—
	10.80	7.51	15.70	5.20	4.23	5.41	—	—
	3.02	1.90	4.31	1.05	0.36	1.45	—	—
	7.78	5.61	11.39	4.15	3.87	3.96	—	—
	0.31	0.23	0.48	0.18	0.16	0.16	—	—
Key metrics
	22.52	17.13	24.32	12.39	11.07	12.25	—	—
	10.40%	9.80%	11.00%	7.40%	6.60%	8.40%	—	—
	3.60%	3.20%	5.20%	2.50%	2.30%	2.70%	—	—
	6.10%	—	12.50%	—	5.80%	—	—	—
	28.50%	20.10%	—	—	—	—	—	—
	101.00%	41.70%	—	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23
Income statement
	780.32	703.06	505.05	463.54	461.33
	8.79	8.71	2.52	2.60	1.12
	789.11	711.77	507.57	466.15	462.45
	749.90	681.23	483.12	450.92	452.95
	48.57	39.06	8.93	6.31	0.32
	702.28	652.13	485.18	424.04	457.25
	8.18	7.44	4.89	3.64	2.98
	32.38	25.70	15.77	8.95	5.40
	4.77	3.79	2.22	1.24	0.91
	33.14	24.93	20.48	14.61	12.72
	39.21	30.54	24.45	15.23	9.50
	0.00	0.00	-2.82	0.00	0.00
	39.21	30.54	21.63	15.23	9.50
	10.28	7.17	5.75	3.77	2.46
	28.93	23.37	15.88	11.46	7.04
	1.20	0.97	0.66	—	—
Key metrics
	76.36	60.03	39.62	25.42	15.81
	9.79%	8.50%	7.80%	5.50%	3.40%
	3.71%	3.30%	3.10%	2.50%	1.50%
	—	30.30%	26.20%	—	—
	—	39.20%	9.00%	0.50%	—
	—	47.20%	38.60%	62.80%	—
	—	-71.40	-26.68	—	—
	—	-0.10	-1.64	—	—
	—	1.81	—	—	—
	—	282.35	—	—	—
	—	137.2	150.8	—	—
Balance sheet
	—	641.75	402.41	—	—
	—	490.26	334.85	—	—
	—	1.13	0.06	—	—
	—	233.34	160.16	—	—
	—	218.74	140.48	—	—
	—	27.33	27.54	—	—
	—	77.41	20.05	—	—
	—	187.72	91.83	—	—
	—	456.12	259.74	—	—
	—	283.48	—	—	—
	—	255.11	—	—	—
	—	28.37	—	—	—
	—	156.32	—	—	—
Cash flow
	—	-2.30	-26.09	—	—
	—	-77.70	-20.41	—	—
	—	80.58	46.87	—	—
	—	69.10	0.59	—	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	205.02	165.66	199.81	158.37	167.01	142.31	—	—
	1.84	1.35	3.21	1.69	2.09	1.42	—	—
	206.86	167.01	203.02	160.06	169.10	143.73	—	—
	195.93	158.88	189.78	154.65	164.27	138.53	—	—
	1.58	1.07	1.06	0.58	0.66	0.68	—	—
	191.75	158.80	193.57	151.78	171.76	138.89	—	—
	1.79	1.73	1.85	1.68	1.40	1.26	—	—
	10.35	8.19	7.27	6.24	6.07	5.71	—	—
	1.26	1.29	1.00	0.81	0.81	0.79	—	—
	10.25	6.47	8.32	7.21	5.15	3.33	—	—
	10.93	8.14	13.23	5.42	4.83	5.19	—	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—
	10.93	8.14	13.23	5.42	4.83	5.19	—	—
	3.14	2.10	3.69	1.11	0.42	1.46	—	—
	7.80	6.04	9.54	4.31	4.40	3.73	—	—
	0.32	0.25	0.40	0.18	0.18	0.15	—	—
Key metrics
	22.54	17.62	21.50	12.47	11.71	11.69	—	—
	11.00%	10.60%	10.80%	7.90%	7.00%	8.20%	—	—
	3.80%	3.60%	4.80%	2.70%	2.60%	2.60%	—	—
	6.20%	—	11.10%	—	6.60%	—	—	—
	22.80%	16.40%	—	—	—	—	—	—
	77.30%	61.90%	—	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23
Income statement
	728.86	667.50	502.51	465.56	461.33
	8.09	8.40	2.88	2.75	1.12
	736.95	675.90	505.38	468.31	—
	699.24	647.24	481.28	453.22	452.95
	4.29	2.98	4.00	4.82	0.32
	695.90	655.99	488.59	427.58	457.25
	7.05	6.19	4.56	3.50	2.98
	32.05	25.30	15.96	9.03	5.40
	4.36	3.41	1.31	1.23	0.91
	32.25	24.01	20.15	14.93	12.72
	37.72	28.67	24.10	15.10	9.50
	0.00	0.00	-2.82	—	—
	37.72	28.67	21.29	15.10	9.50
	10.04	6.69	5.41	3.74	2.46
	27.69	21.98	15.88	11.36	7.04
	1.15	0.91	0.66	—	—
Key metrics
	74.13	57.38	38.56	25.36	15.81
	10.17%	8.60%	7.70%	5.40%	3.40%
	3.80%	3.30%	3.20%	2.40%	1.50%
	—	29.30%	26.20%	—	—
	—	32.80%	7.90%	0.90%	—
	—	38.40%	39.80%	61.40%	—
	—	-52.74	-28.38	—	—
	—	-0.13	-1.75	—	—
	—	1.84	—	—	—
	—	280.98	—	—	—
	—	141.5	151.5	—	—
Balance sheet
	—	594.18	400.40	—	—
	—	444.75	333.83	—	—
	—	0.11	0.06	—	—
	—	199.23	159.63	—	—
	—	206.66	137.04	—	—
	—	26.34	27.30	—	—
	—	72.77	19.46	—	—
	—	147.12	88.01	—	—
	—	410.05	257.98	—	—
	—	281.09	—	—	—
	—	250.70	—	—	—
	—	30.39	—	—	—
	—	152.71	—	—	—
Cash flow
	—	-2.75	-27.85	—	—
	—	-79.71	-20.24	—	—
	—	82.18	48.35	—	—
	—	49.99	0.53	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +13.10%
Sales CAGR 5Y: —
Profit CAGR 3Y: +46.16%
Profit CAGR 5Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Consolidated

Sales CAGR 3Y: +15.08%
Sales CAGR 5Y: —
Profit CAGR 3Y: +49.17%
Profit CAGR 5Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 57.82%

Quarter	30 Sep 2026	September 2026	June 2026
Promoter %	57.82%	57.82%	58.94%

Holder	Type	Holding	Previous	Change
SACHIN VASANTRAI MEHTA	Promoter	27.79%	27.79%	0.00%
HEMAL VASANTRAI MEHTA	Promoter	26.93%	26.93%	0.00%
CENTURY INDIA OPPORTUNITY FUND PC	Public	3.18%	3.18%	0.00%
SAUMIK KETANKUMAR DOSHI	Public	2.83%	2.83%	0.00%
EMINENCE GLOBAL FUND PCC- EUBILIA CAPITAL PARTNERS	Public	2.77%	2.77%	0.00%
EBISU GLOBAL OPPORTUNITIES FUND LIMITED	Public	1.93%	1.93%	0.00%
Unbounded Opportunities Fund SPC –Alpha Investments SP	Public	1.89%	1.89%	0.00%
NORTH STAR OPPORTUNITIES FUND VCC-BULL VALUE INCOR	Public	1.65%	1.65%	0.00%
COEUS GLOBAL OPPORTUNITIES FUND	Public	1.65%	1.65%	0.00%
MINERVA VENTURES FUND	Public	1.57%	1.57%	0.00%
BRIDGE INDIA FUND	Public	1.56%	1.56%	0.00%
NEXPACT LIMITED	Public	1.51%	1.51%	0.00%
PINE OAK GLOBAL FUND	Public	1.26%	1.26%	0.00%
DEVANGI HEMAL MEHTA	Promoter Group	0.90%	0.90%	0.00%
HEMAL V MEHTA HUF .	Promoter Group	0.65%	0.65%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Pidilite Industries Ltd.	1,53,494	1,507.00	56.47	28.50%	+16.83% TTM	+20.94% TTM	+3.57%
Gujarat Fluorochemicals Limited	50,673	4,612.90	75.63	10.10%	+20.33% TTM	-1.47% TTM	+25.63%
Navin Fluorine International Limited	45,075	8,785.00	49.50	18.70%	+45.68% TTM	+105.04% TTM	+45.12%
Deepak Nitrite Limited	21,559	1,580.65	20.29	10.80%	+23.80% TTM	+99.83% TTM	-9.73%
Aether Industries Limited	20,478	1,542.85	82.16	12.20%	+30.76% TTM	+28.03% TTM	+103.85%
Aarti Industries Ltd	16,311	449.65	27.46	8.50%	+39.85% TTM	+104.40% TTM	+16.66%
Fine Organic Industries Limited	15,720	5,127.35	38.71	20.20%	+12.92% TTM	+18.80% TTM	+16.19%
Atul Limited.	15,177	5,155.00	19.28	13.50%	+18.15% TTM	+40.10% TTM	-12.49%
Anupam Rasayan India Limited	13,029	1,144.40	57.92	7.50%	+51.76% TTM	+14.65% TTM	+6.58%
PRIVI SPECIALITY CHEMICALS LIMITED	12,825	3,283.30	34.73	25.10%	+17.54% TTM	+44.15% TTM	+10.09%
BASF India Ltd	12,812	2,959.95	21.44	13.10%	+13.35% TTM	+59.30% TTM	-33.46%
Sudeep Pharma Limited	12,657	1,120.60	67.10	24.20%	—	—	—
Vinati Organics Ltd.	10,334	996.85	25.09	17.70%	+10.98% TTM	-5.48% TTM	-39.90%
Elantas Beck India Ltd S	10,127	12,774.65	54.20	—	+18.86% TTM	+35.25% TTM	+29.29%
Jubilant Ingrevia Limited	8,957	562.35	25.55	10.80%	+15.41% TTM	+21.73% TTM	-18.43%
Alkyl Amines Chemicals Ltd. S	8,108	1,585.25	32.77	14.60%	+13.38% TTM	+35.83% TTM	-13.31%
Galaxy Surfactants Limited	8,048	2,269.80	22.75	12.70%	+27.05% TTM	+16.13% TTM	+0.01%
Clean Science and Technology Limited	6,979	656.60	29.92	19.20%	+4.51% TTM	-12.06% TTM	-33.34%
Neogen Chemicals Limited	6,815	2,268.40	168.60	6.80%	+26.66% TTM	+55.16% TTM	+54.05%
Fineotex Chemical Limited	6,221	53.42	41.98	16.20%	+91.44% TTM	+41.07% TTM	+84.27%
Balaji Amines Ltd.	5,738	1,770.80	23.80	10.20%	+20.91% TTM	+66.05% TTM	+26.00%
Archean Chemical Industries Limited	5,291	428.60	54.04	7.80%	+5.99% TTM	-42.66% TTM	-34.05%
Prasol Chemicals Limited	4,594	776.20	—	—	—	—	—
Laxmi Organic Industries Limited	4,501	161.95	35.81	4.40%	+5.47% TTM	+25.01% TTM	-17.12%
Foseco India Ltd S	4,494	5,962.25	57.00	—	+10.33% TTM	-3.71% TTM	+5.42%
SUDARSHAN PHARMA INDUSTRIES LIMITED	810	32.45	28.54	30.30%	—	—	+13.26%

Some figures use IPO-document inputs. Growth periods are shown per value; FY means annual.

Filings & corporate actions

Recent announcements

In continuation of the Company''s letter dated 30/Oct/2026 (ref. no. SPIL/CS/2026-2027/72), the Board of Directors at its Meeting held on 29/Oct/2026 have approved the proposal to raising ....30 Oct 2026 · Company Update / Issue of Securities
This is to inform you that the Board of Directors of the Company at its Board Meeting held on 29/Oct/2026 has approved the proposal to raising funds through issue and allotment of up to ....30 Oct 2026 · Company Update / Issue of Securities
We are submitting the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30/Sep/202629 Oct 2026 · Result / Financial Results
Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve i) Unaudited Standalone ....26 Oct 2026 · Board Meeting / Board Meeting
We are pleased to inform you that the Company ahs received letter from National Stock Exchange of India Limited dated 23-Oct-2026 stating that the equity shares of the Company shall be ....23 Oct 2026 · Company Update / General
In continuation of the Company''s letters dated 05/Sep/2026 and 15/Sep/2026, this is to inform you that the proposal to acquire 9.50% equity shares of common stock of Med Therapy Biotechnology ....7 Oct 2026 · Company Update / Acquisition
Please find attached copy of certificates under Regulation 74(5) of SEBI ( Depository And Participants ) Regulations, 2018, received from Kfin Technologies Limited for the quarter ended ....7 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The Trading Window of the Company shall remain closed with effect from October 1,2026 until the expiry of 48 hours after the declaration of financial results for the quarter and half year ....30 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in conitinuation of the Company''s letter dated 13/Aug/2026 regarding stake sale ....28 Sep 2026 · Company Update / Diversification / Disinvestment
Please find enclosed the Scrutinizer''s Report on the business transacted at the 18th Annual General Meeting of the company held on Tuesday 22/SEPT/2026 through video conferencing / other ....22 Sep 2026 · AGM/EGM / AGM
Please find enclosed the voting results on the business transacted at the 18th Annual General Meeting of the company held on Tuesday 22/SEPT/2026 at 3:00 p.m. through Video Conferencing/ ....22 Sep 2026 · AGM/EGM / AGM
Pursuant to Regulation 30 of SEBI ( Listing Obligations and Disclosure Requirements ) Regulations, 2015 we enclose herewith the summary of proceedings of the AGM.22 Sep 2026 · AGM/EGM / AGM
Pursuant to Reg 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation of the Company letter no. SPIL/CS/2026-2027/57 dated 5th September 2026, ....15 Sep 2026 · Company Update / Acquisition
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 09, 2026 for Hemal V ....9 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 09, 2026 for Hemal Vasantrai Mehta9 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directros have at their Meeting held today, ....5 Sep 2026 · Company Update / Acquisition
Please find enclosed the newpaper advertisement for the Notice of 18th Annual General Meeting to be held on Yesday, 22nd September 2026 at 3.00 pm published in (1) Mumbai Lakshdeep (Marathi) ....1 Sep 2026 · Company Update / Newspaper Publication
Pursuant to Reg 34 of SEBI Listing Regulations, please find enclosed the Annual Report of the Company for the FY 2025-26.29 Aug 2026 · Others / Reg. 34 (1) Annual Report
Pursuant to Reg 34 of SEBI Listing Regulations, please find enclosed the Annual Report of the Company for the FY 2025-26.29 Aug 2026 · Others / Reg. 34 (1) Annual Report
Pursuant to Regulation 34 of SEBI Listing Regulations, please find enclosed the Notice of 18th Annual General Meeting to be held on Tuesday, 22/September/2026.29 Aug 2026 · AGM/EGM / AGM
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 26, 2026 for Hemal V Mehta & Sachin V Mehta26 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 21, 2026 for Hemal V Mehta & Sachin V Mehta22 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
It is hereby informed that the members of the FCCB COmmittee of the COmpany, have at their meeting held today, 19/Aug/2026, have approved allotment of 48,11,730 fully paid-up equity shares ....19 Aug 2026 · Company Update / Allotment of Equity Shares
Please find enclosed the newspaper advertisement for the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30/June/2026 published in (i) Mumbai Lakshdeep (Marathi) ....18 Aug 2026 · Company Update / Newspaper Publication
Pursuant to Regulation 30 of SEBI LODR Regulations, We hereby submit the updated Investor Presentation18 Aug 2026 · Company Update / Investor Presentation
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 14, 2026 for Vasantrai Ratilal ....17 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
A Meeting of the FCCB Committee of the Company is scheduled on Wednesday, 19-August-2026 to consider and approve conversion a portion of funds raised through FCCBs into equity shares and ....14 Aug 2026 · Company Update / General
We hereby submit the presentation on the manufacturing plant proposed to be acquired by the Company.14 Aug 2026 · Company Update / Investor Presentation
The Company has entered into a Memorandum of Understanding to acquire 1,24,64,000 equity shares of Rs.10/- each of the target company (76% of paid up equity share capital). The acquisition ....13 Aug 2026 · Company Update / Acquisition
The Board of Directors at their Meeting held on 12/August/2026 approved the divestment of 2,09,100 equity shares (51.00% of paid up share capital) of Ishwari Healthcare Private Limited. ....13 Aug 2026 · Company Update / Diversification / Disinvestment
The Board of Directors at their meeting held on 12/August/2026 approved to acquire 3,000 equity shares (30.00% of paid up capital) of Sudarshan Maven Pharma Private Limited. Upon acqusition, ....13 Aug 2026 · Company Update / Acquisition
Please find attached the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30/06/202612 Aug 2026 · Result / Financial Results
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 08, 2026 for Hemal Vasantrai Mehta10 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Unaudited Standalone ....9 Aug 2026 · Board Meeting / Board Meeting
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 14, 2026 for Hemal Vasantrai Mehta14 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Please find attached copy of certificates under Regulation 74(5) of SEBI (Depository And Participants) Regulations, 2018, received from Kfin Technologies Limited for the quarter ended 30/June/2026.7 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The Trading Window of the Company shall remain closed with effect from 01/July/2026 untill the expiry of 48 hours after the declaration of the financial results for the quarter ended 30/June/2026.30 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Please find enclosed the Scrutinizer''s Report on the business transacted through postal ballot notice dated 21/May/2026 which was open for voting from 26/May/2026 to 24/June/2026.25 Jun 2026 · AGM/EGM / Postal Ballot
Please find enclosed the voting results on the business transacted through postal ballot notice dated 21/May/2026 which was open for voting from 26/May/2026 to 24/June/2026.25 Jun 2026 · AGM/EGM / Postal Ballot
We would like to inform you that the Meeting of the Board of Directors of the COmpany scheduled today, Thursday, 18/June/2026 stands cancelled due to unavoidable reasons.18 Jun 2026 · Board Meeting / Outcome of Board Meeting

Corporate actions

Purpose	Ex date	Record date	Payment date
Stock Split From Rs.10/- to Rs.1/-	22 Nov 2024	23 Nov 2024	—

Board meetings

29 Oct 2026 Board Meeting - Financial Results
12 Aug 2026 Board Meeting - Financial Results